Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option*

OBJECTIVE: Removal of cardiac autoantibodies by immunoadsorption might confer clinical improvement in dilated cardiomyopathy. In this pilot study, we investigated the efficacy and safety of immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy. METHODS: This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavusoglu, Yuksel, Tahmazov, Senan, Murat, Selda, Akay, Olga Meltem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937600/
https://www.ncbi.nlm.nih.gov/pubmed/36629647
http://dx.doi.org/10.1590/1806-9282.20220784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937600/
https://www.ncbi.nlm.nih.gov/pubmed/36629647
http://dx.doi.org/10.1590/1806-9282.20220784

Ejemplares similares